Børsen
Novo Nordisk’s weight loss drug Ozempic and the ADHD medication Elvanse are draining the regions’ finances, reports the vice-chairman of the Danish Regions. They want better control of the spiraling expenses.
Novo Nordisk’s weight loss drug Ozempic and the ADHD medication Elvanse are draining the regions’ finances, reports the vice-chairman of the Danish Regions. They want better control of the spiraling expenses.